-
Dr. Joseph Ornato presented the Public Access Defibrillation (PAD) study, which evaluated the efficacy of out-of-hospital cardiac arrest treatment by cardiopulmonary resuscitation (CPR) alone vs CPR plus
use of an automatic external defibrillator (AED) performed by trained laypersons.
-
Studies of selected patients with ischemic cardiomyopathy have shown improved survival with the use of prophylactic implantable cardioverter
defibrillators (ICD). Thus, DEFibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) was designed to test the survival benefit of ICDs in patients with heart failure but without coronary artery disease.
-
The efficacy and safety study of oral direct thrombin Inhibitor Ximelagatran Compared with Dose-Adjusted Warfarin in the Prevention of Stroke and Systemic Embolic Events in Patients with Atrial Fibrillation (SPORTIF V) was presented by Dr. Jonathan Halperin.
-
In this study, Blackshear and colleagues report on their experience with thoracoscopic surgical techniques to close the left atrial appendage as prophylaxis against stroke in patients with atrial fibrillation.
-
-
In this report, Higgins and colleagues report on a multicenter trial on the efficacy of cardiac resynchronization therapy in patients with an indication for an implantable cardioverter defibrillator.
-
The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.
-
Blood pressure reduction in the first 24 hours of stroke onset is independently associated with poor outcome after 3 months.
-
In this study, fecal incontinence therapies, including standard care (advice), sphincter exercises, and computer-assisted biofeedback, all led to substantial improvements in continence, quality of life, psychological well being, and sphincter function with no evidence of superiority for biofeedback.
-